New data examine infliximab as a treatment option, and updated diagnostic criteria aids physicians in recognizing KD and detecting cardiac involvement in patients
Letters: A Word of Caution on Colchicine Study
A rheumatologist warns against generalizing findings of the study reported in “Colchine Effective for Acute Pericarditis” [published online October 31, 2013] to all patients with rheumatic diseases
Parents Give Back after Watching Daughter’s Struggle with Systemic Juvenile Idiopathic Arthritis
Diagnosis prompts Steve and Debbie Russell to support the Rheumatology Research Foundation
2014 Pediatric Rheumatology Symposium Scheduled April 3–6 in Orlando, Florida
Conference to feature practice management tips and latest findings in clinical, translational, and basic research on treating rheumatic diseases in children
Rheuminations: Road to Success in Medicine May Be Paved with Failure
How healthcare has benefited from breakthrough discoveries related to bovine spongiform encephalitis, H. pylori ulcer disease, and properdin by researchers who persevered despite criticism from skeptics
2013 ACR/ARHP Annual Meeting: Better Care for Pediatric Rheumatology Patients On Horizon
A robust workforce, flourishing clinical trials, broad patient registries, and consensus treatment protocols contribute to improvements for the subspecialty
Rheumatologists On The Move
Awards, appointments, and announcements in the world of rheumatology
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
2013 ACR/ARHP Annual Meeting: Genetic Research Yields Clues to Pathogenesis of Rheumatoid Arthritis, Psoriatic Arthritis
Studies determine that both RA and PsA are autoimmune diseases and link disease susceptibility to certain alleles that encode the major histocompatibility complex, HLA
2013 ACR/ARHP Annual Meeting: Researchers Explore Role of Pathogens, Quality of Care in Rheumatoid Arthritis
Funding by the Rheumatology Research Foundation has furthered studies on the impact of infectious agents and autoantigens, periodontal disease, and disease-modifying antirheumatic drugs on patients with RA
- « Previous Page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- …
- 78
- Next Page »